Tejera-Vaquerizo, AntonioBoada, AramRibero, SimonePuig, SusanaParadela, SabelaMoreno-Ramirez, DavidCanueto, Javierde Unamuno-Bustos, BlancaBrinca, AnaDescalzo-Gallego, Miguel A.Osella-Abate, SimonaCassoni, PaolaPodlipnik, SebastianCarrera, CristinaVidal-Sicart, SergiPigem, RamonToll, AgustiRull, RamonAlos, LluciaRequena, CeliaBolumar, IsidroTraves, VictorPla, AngelFernandez-Orland, AlmudenaJaka, AneFernandez-Figueras, Maria TeresaRicharz, Nina AnikaVieira, RicardoBotella-Estrada, RafaelRoman-Curto, ConcepcionFerrandiz-Pulido, LaraIglesias-Pena, NicolasFerrandiz, CarlosMalvehy, JosepQuaglino, PietroNagore, Eduardo2025-01-072025-01-072021-12-01https://hdl.handle.net/10668/27660The therapeutic value of sentinel lymph node biopsy (SLNB) in thin melanoma remains controversial. The aim of this study is to determine the role of SLNB in the survival of thin melanomas (enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/melanomasentinel lymph node biopsysurvivalPrimary cutaneous melanomaSpanish academyPositivityAssociationDermatologyProgressionMetastasisPredictorsRegressionStatementSentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Studyresearch article34945175open access10.3390/jcm102458782077-0383https://www.mdpi.com/2077-0383/10/24/5878/pdf?version=1639555987737825700001